Altman Clinical and Translational Research Institute, University of California San Diego Health Center, San Diego, CA, USA
Review Article
Nanotechnology: Role Development Impact of Nanomedicine on Covid-19 Pandemic Management
Author(s): Erum Alia*
Extensive reports of pulmonary embolisms, ischaemic stroke and myocardial infarctions caused by coronavirus disease
2019 (COVID-19), as well as a significantly increased long-term risk of cardiovascular diseases in COVID-19 survivors, have
highlighted severe deficiencies in our understanding of thromboinflammation and the need for new therapeutic options. Due
to the complexity of the immunothrombosis pathophysiology, the efficacy of treatment with conventional anti-thrombotic
medication is questioned. Thrombolytics do appear efficacious, but are hindered by severe bleeding risks, limiting their use.
Nanomedicine can have profound impact in this context, protecting delicate (bio) pharmaceuticals from degradation en route
and enabling delivery in a targeted and on demand manner. We provide an overview of the most promising nanocarrier systems
and design strategies t.. View more»